Open access
Sep 2026
Preclinical evaluation of ixazomib for high-risk pediatric brain tumors
Using transcriptomic and proteomic approaches, ixazomib effectively triggers proteostatic stress responses and induces apoptosis across a histologic range of CNS malignancies and is effective against Myc-MB, ATRT and DMG tumors in vitro.
Elizabeth Janko, Faye Walker, Mathew Slade et al.
· bioRxiv · 0 citations